From GlobeNewswire: 2025-05-07 08:37:00

Syntec Optics Holdings, Inc. is developing non-incisional optics-based refractive error correction to treat near vision loss in 128 million Americans. The company aims to provide safer, quicker, and more effective treatment options for this common age-related condition. With a global market value of USD 20.3 billion in 2025, the demand for advanced treatment solutions for myopia and presbyopia is on the rise. Syntec Optics is leveraging its advanced manufacturing capabilities to support the clinical development of non-incisional optical solutions, offering a promising alternative to traditional surgical interventions. This move underscores the company’s commitment to advancing healthcare through innovative manufacturing.



Read more at GlobeNewswire: OPTX) Enabling Optics for Near